The first apicoplast tRNA thiouridylase plays a vital role in the growth of Toxoplasma gondii
Yimin Yang,Mi Lin,Xueqiu Chen,XianFeng Zhao,Lulu Chen,Mingxiu Zhao,Chaoqun Yao,Kaiyin Sheng,Yi Yang,Guangxu Ma,Aifang Du
DOI: https://doi.org/10.3389/fcimb.2022.947039
IF: 6.073
2022-08-15
Frontiers in Cellular and Infection Microbiology
Abstract:Toxoplasmosis caused by the protozoan Toxoplasma gondii is one of the most common parasitic diseases in humans and almost all warm-blooded animals. Lys, Glu, and Gln-specific tRNAs contain a super-modified 2-thiourea (s 2 U) derivatives at the position 34, which is essential for all living organisms by maintaining the structural stability and aminoacylation of tRNA, and the precision and efficiency of codon recognition during protein translation. However, the enzyme(s) involved in this modification in T. gondii remains elusive. In this report, three putative tRNA-specific 2-thiolation enzymes were identified, of which two were involved in the s 2 U34 modification of tRNA Lys , tRNA Glu , and tRNA Gln . One was named Tg MnmA, an apicoplast-located tRNA-specific 2-thiolation enzyme in T. gondii . Knockout of TgMnmA showed that this enzyme is important for the lytic cycle of tachyzoites. Loss of Tg MnmA also led to abnormities in apicoplast biogenesis and severely disturbed apicoplast genomic transcription. Notably, mice survived from the infection with 10 Tg MnmA-KO RH tachyzoites. These findings provide new insights into s 2 U34 tRNA modification in Apicomplexa, and suggest Tg MnmA, the first apicoplast tRNA thiouridylase identified in all apicomplexans, as a potential drug target.
immunology,microbiology